| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 6.7% | $7,636,000 | 440,000 | Leonard Braden Michael | 31 Dec 2024 |
As of 30 Sep 2025, 1 institutional investors reported holding 1,899,004 shares of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL). This represents 29% of the company’s total 6,567,164 outstanding shares.
The largest institutional shareholders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Curative Ventures V LLC | 29% | 1,899,004 | 0% | 100% | $33,916,211 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1,899,004 | $33,916,211 | $17.86 | 1 | |
| 2025 Q2 | 1,899,004 | $39,556,253 | $20.83 | 1 | |
| 2025 Q1 | 1,899,004 | $32,966,709 | $17.36 | 1 | |
| 2024 Q4 | 1,899,004 | $36,251,986 | $19.09 | 1 | |
| 2024 Q3 | 1,899,004 | $127,840,949 | $0 | $67.32 | 1 |
| 2024 Q2 | 1,899,004 | $19,540,751 | $0 | $10.29 | 1 |
| 2024 Q1 | 1,899,004 | $20,509,243 | $0 | $10.80 | 1 |
| 2023 Q4 | 1,899,004 | $14,470,411 | -$289,481,607 | $7.62 | 1 |
| 2023 Q3 | 80,213,679 | $34,331,150 | -$1,093,460 | $0.43 | 55 |
| 2023 Q2 | 82,119,365 | $45,244,880 | -$5,610,482 | $0.55 | 57 |
| 2023 Q1 | 92,102,950 | $60,866,539 | -$6,263,759 | $0.66 | 70 |
| 2022 Q4 | 89,280,197 | $56,246,846 | -$78,926,949 | $0.63 | 70 |
| 2022 Q3 | 118,636,336 | $574,197,359 | -$127,679 | $4.84 | 84 |
| 2022 Q2 | 114,684,181 | $529,831,836 | -$18,684,762 | $4.62 | 88 |
| 2022 Q1 | 79,917,762 | $859,091,567 | +$16,428,984 | $10.75 | 72 |
| 2021 Q4 | 78,058,337 | $1,335,481,956 | +$128,556,061 | $17.11 | 73 |
| 2021 Q3 | 71,870,373 | $1,284,803,308 | +$23,130,670 | $17.88 | 63 |
| 2021 Q2 | 69,297,488 | $1,333,870,574 | +$94,985,082 | $19.32 | 61 |
| 2021 Q1 | 65,033,804 | $1,617,866,000 | +$1,617,866,101 | $25.08 | 56 |